NRIX vs QCOM · rev $54.5M vs P/E 16, rev $44.28B
Nurix Therapeutics Inc (NRIX) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
NRIX currently screens at market cap $1.77B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the NRIX and QCOM stock pages for the full models.
Not investment advice.